Viewing Study NCT04793269


Ignite Creation Date: 2025-12-24 @ 10:59 PM
Ignite Modification Date: 2025-12-25 @ 8:28 PM
Study NCT ID: NCT04793269
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-30
First Post: 2021-03-04
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Characteristics of Long COVID-19 Syndrome
Sponsor: Christian Clarenbach
Organization:

Study Overview

Official Title: Long COVID Syndrom: Charakterisierung Eines Neuen Krankheitsbildes
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Characterization of patients with long COVID syndrome including symptoms, medical history and persistent organ damage.
Detailed Description: Some people are very hesitant to recover from a COVID-19 infection and present persistent symptoms. The participants still suffer after the acute phase of the infection from shortness of breath, coughing, chest pain or fatigue. Therefore, a special interdisciplinary consultation was built. The consulatation is not only addressed to people who have been hospitalized due to COVID-19, but also to those with mild symptoms during infection. During the consultation hours, personal health data are collected that serves as the basis for this research project.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: